This content is from: Structured Finance & Securitisation

How Asian OTC derivatives reporting regimes compare

In the first part of a three part series, a senior lawyer at a US investment bank in Asia analyses the divergent regimes for OTC reporting in Hong Kong and Singapore

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial